Article Text

Download PDFPDF
Delayed therapeutic success with endoscopic cyclophoto-coagulation in treating refractory post-penetrating keratoplasty glaucoma
  1. D A Hollander,
  2. S C Lin
  1. Department of Ophthalmology, The University of California, San Francisco, San Francisco, CA, USA
  1. Correspondence to: Shan C Lin, MD, University of California, San Francisco, Department of Ophthalmology, 10 Koret Way, Suite K-301, San Francisco, CA 94143, USA; shanl{at}itsa.ucsf.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Endoscopic cyclophotocoagulation (ECP) was introduced as an alternative to trans-scleral cyclophotocoagulation for treating refractory glaucomas in order to minimise complications such as phthisis and hypotony by providing direct visualisation of the ciliary processes.

Glaucoma following penetrating keratoplasty, which has an incidence ranging from 10–52%, often proves refractory to medical treatment.1–3 We introduce a case of refractory post-PKP glaucoma in order to demonstrate the efficacy of ECP in treating post-PKP glaucoma and to describe its potential delayed effect in achieving intraocular pressure control .

Case report

A 50 year old African-American man, who had undergone previous cataract surgery, anterior vitrectomy, and anterior chamber intraocular lens placement in his left eye in 1987, presented with pseudophakic bullous keratopathy and hand movement vision in his left eye. In April of 2000, the patient underwent a penetrating keratoplasty in which an 8 mm donor …

View Full Text